# DAVITA INC. (DVA) FY2026 Q3 Revenue by Business Segment (2 categories)

- Company: DAVITA INC. (DVA)
- Statement: DAVITA INC. (DVA) FY2026 Q3 P&L / Income Statement, https://plicit.ai/financials/dva/fy2026-q3-income-statement
- Period: 2026-07-01 to 2026-09-30
- Filing: Q3 FY2026 10-Q, filed 2026-10-29, accession number 0000927066-26-000134
- Page: https://plicit.ai/financials/dva/fy2026-q3-income-statement/revenue-by-business-segment-2-categories
- Chart image: https://plicit.ai/charts/dva-fy2026-q3-revenue-by-business-segment-2-categories-sankey.png

## Chart details: Revenue by Business Segment (2 categories)

Income statement for 2026-07-01 through 2026-09-30. View: Business segment (2 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 3,578,126,000 US dollars
- **Total operating expenses**: 3,078,871,000 US dollars
- **Operating income**: 499,255,000 US dollars
- **Other income (expense), net (calculated)**: negative 140,548,000 US dollars
- **Income before income taxes**: 358,707,000 US dollars
- **Income tax expense**: 89,318,000 US dollars
- **Net income**: 269,389,000 US dollars
- **U. S. Dialysis And Related Lab Services**: 3,028,470,000 US dollars
- **Other Operating Segment**: 549,656,000 US dollars
- **Patient care costs**: 2,451,047,000 US dollars
- **General and administrative**: 408,697,000 US dollars
- **Depreciation and amortization**: 165,188,000 US dollars
- **Equity investment income, net**: negative 8,237,000 US dollars
- **Goodwill and other asset impairment charges**: 62,176,000 US dollars

### Chart connections

- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Of which attributable to DAVITA INC.: $222.93 M; to noncontrolling interests: $46.46 M.

## Key Takeaways

- Other operating segments grew sales 22% to $549.66 M, yet swung to an $18.64 M operating loss.
- Management's adjusted measure puts these businesses' operating income at $44 million, not a loss.
- U.S. dialysis kept 18% of its $3.03 B in sales as operating income this quarter.
- Combined segment margin fell 0.8 points from a year earlier, to 14.7% of sales.

## The Unvarnished Truth

### DaVita's fastest-growing business swung to an $18.64 M quarterly loss

DaVita's smaller business line grew fastest and lost money. Its other operating segments lifted sales 22% to $549.66 M, yet posted an $18.64 M operating loss against a $1.22 M profit a year earlier. These segments are mainly integrated kidney care and the international clinics. The culprit is the $62.18 M write-down of the business in China. Strip it out and management's adjusted operating income for these businesses was $44 million. So the loss stems from the charge, but that charge is a warning about what the expansion abroad is worth.

Why did the core not offset it? U.S. dialysis, 85% of sales, grew just 2.0% and earned $544.18 M of operating income, against $530.11 M a year earlier. That is a margin of 18%, steady but not spectacular. Together the segments earned $525.54 M before head-office costs, down from $531.33 M. Their blended margin slipped 0.8 points, to 14.7%. Head-office costs and other items then trimmed the total to $499.26 M of operating income. The growth engine, in other words, is the business that just took the write-down.

For investors the split is a warning. Dialysis grows slowly and profitably; the faster-growing segments are where DaVita is placing its bets, and they are where value just evaporated. Management blames adverse reimbursement rate changes in non-renal hospital services in China, and the goodwill note says the unit remains at risk. Watch the adjusted operating income of the international clinics and whether these segments can turn growth into profit without further write-downs. If these segments keep growing fast while losing money on paper, are they building value or burning it?

## Intelligent Insights for Investors

### How profitable is each of DaVita's businesses?

U.S. dialysis is the most profitable: it kept 18% of its sales as operating income this quarter. The other operating segments posted a loss equal to 3.4% of their sales.

### Which of DaVita's businesses drove its profit change over the past year?

The other operating segments alone: their result fell by $19.86 M from a year earlier, more than the segments' combined operating profit fell overall, because U.S. dialysis moved the other way.

### How much do head-office costs take out of DaVita's business profits?

Its businesses earned $525.54 M of operating income this quarter. After head-office costs and other items kept outside them, $499.26 M was left.

## Intelligent Insights for Employees

### Is any of DaVita's businesses losing money?

Yes: the other operating segments lost $18.64 M this quarter on their operating income measure, equal to 3.4% of their sales.

## Intelligent Insights for Everyone

### Which of DaVita's businesses brings in the most sales?

U.S. dialysis and related lab services carries the sales, with 85% this quarter. Next come the other operating segments, at 15%.
